ロード中...
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
The aim of this review is to update the current status of allogeneic hemopoietic stem cell transplants (HSCT) for patients with myelofibrosis (MF). We have first summarized the issue of an indication for allogeneic HSCT, discussing several prognostic scoring systems, developed to predict the outcome...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8129535/ https://ncbi.nlm.nih.gov/pubmed/34017327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.637512 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|